Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway.
Ling-Li LiLi WeiNing ZhangWen-Ying WeiCan HuDeng WeiQi-Zhu TangPublished in: BioMed research international (2020)
Levosimendan may protect against DOX-induced cardiotoxicity via modulation of the PTEN/Akt signaling pathway.